CANINE ATOPIC DERMATITIS (CAD) - PHASE 3 CLINICAL TRIALS IN AUSTRALIA

Canine atopic dermatitis (CAD) is a genetic, ongoing, and itchy skin condition in dogs. It's linked to environmental allergens and often requires lifelong management. CAD commonly causes moderate to severe itching, along with redness, skin eruptions, hair loss, scratches, darkened skin, and thickening. The affected skin can also face additional challenges due to infections with Staphylococcus pseudintermedius and Malassezia pachydermatis. This condition impacts both the well-being of dogs and their owners.

Invetus Clinical Network (ICN) conducts CAD Phase 3 Clinical Trials in Australia. Cases are recruited through specialist veterinary dermatologist clinics with access to patient pools in major metropolitan cities in Australia.

 
 

Invetus provides:

  • Effective Case Recruitment

  • Multi-Centre Studies

  • Single Point of Contact

  • GCP Quality Standard

  • Trained Invetus Investigators